Search Results - "Paassen, Pieter"

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis by Jones, Rachel B, Cohen Tervaert, Jan Willem, Hauser, Thomas, Luqmani, Raashid, Morgan, Matthew D, Peh, Chen Au, Savage, Caroline O, Segelmark, Mårten, Tesar, Vladimir, van Paassen, Pieter, Walsh, Michael, Walsh, Dorothy, Westman, Kerstin, Jayne, David R.W

“…A standard glucocorticoid regimen plus rituximab was not superior to standard intravenous cyclophosphamide as induction therapy in patients with newly…”
Get full text

Spondylitis as a Rare Manifestation of Granulomatosis With Polyangiitis by Busch, Matthias H., Aendekerk, Joop P., Oude Lashof, Astrid M. L., Paassen, Pieter

Get full text

The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives by Timmermans, Sjoerd A. M. E. G., Werion, Alexis, Spaanderman, Marc E. A., Reutelingsperger, Chris P., Damoiseaux, Jan G. M. C., Morelle, Johann, Paassen, Pieter

“…Summary Pregnancy has been linked to various microangiopathies, including primary atypical haemolytic uraemic syndrome (aHUS). Complement dysregulation, often…”
Get full text

Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity by Tobal, Rachid, Potjewijd, Judith, van Empel, Vanessa P M, Ysermans, Renee, Schurgers, Leon J, Reutelingsperger, Chris P, Damoiseaux, Jan G M C, van Paassen, Pieter

“…Pulmonary arterial hypertension (PAH) is a severe disease with high morbidity and mortality. Current therapies are mainly focused on vasodilative agents to…”
Get full text

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial by Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, Paassen, Pieter, Empel, Vanessa P.M., Heymans, Stephane R.B.

“…Aims Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy…”
Get full text

Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients by Paassen, Pieter van, Pittrow, David, Scheidegger, Clemens, Klotsche, Jens, Ellerbroek, Pauline M

“…Data on the real-world use of hyaluronidase-facilitated subcutaneous 10% immunoglobulin (fSCIG; HyQvia ) in elderly patients with primary or secondary…”
Get full text

The anti‐C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID‐19 by Vlaar, Alexander P. J., Lim, Endry H. T., Bruin, Sanne, Rückinger, Simon, Pilz, Korinna, Brouwer, Matthijs C., Guo, Ren‐Feng, Heunks, Leo M. A., Busch, Matthias H., Paassen, Pieter, Riedemann, Niels C., Beek, Diederik

“…Recently, we reported the phase II portion of the adaptive phase II/III PANAMO trial exploring potential benefit and safety of selectively blocking C5a with…”
Get full text

Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays by Rasmussen, Niels, Damoiseaux, Jan, Csernok, Elena, Heegaard, Niels H H, Hellmich, Bernhard, Paassen, Pieter van, Baslund, Bo, Vermeersch, Pieter, Blockmans, Daniel, Tervaert, Jan-Willem Cohen, Bossuyt, Xavier

Get more information

Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays by Damoiseaux, Jan, Csernok, Elena, Rasmussen, Niels, Moosig, Frank, van Paassen, Pieter, Baslund, Bo, Vermeersch, Pieter, Blockmans, Daniel, Cohen Tervaert, Jan-Willem, Bossuyt, Xavier

“…This multicentre study was performed to evaluate the diagnostic accuracy of a wide spectrum of novel technologies nowadays available for detection of…”
Get more information

Diagnostic and Risk Factors for Complement Defects in Hypertensive Emergency and Thrombotic Microangiopathy by Timmermans, Sjoerd A.M.E.G., Wérion, Alexis, Damoiseaux, Jan G.M.C., Morelle, Johann, Reutelingsperger, Chris P., van Paassen, Pieter

“…Hypertensive emergency can cause thrombotic microangiopathy (TMA) in the kidneys with high rates of end-stage renal disease (ESRD) and vice versa. The…”
Get full text

Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19 by Busch, Matthias H, Timmermans, Sjoerd A M E G, Aendekerk, Joop P, Ysermans, Renée, Amiral, Jean, Damoiseaux, Jan G M C, Reutelingsperger, Chris P, Paassen, Pieter van

“…Severe coronavirus disease 2019 (COVID-19) is characterized by hyperinflammation, vascular damage, and hypercoagulability. Insufficient responses of Annexin A1…”
Get full text

Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy by Timmermans, Sjoerd A.M.E.G., BSc, Ayalon, Rivka, MD, van Paassen, Pieter, MD, PhD, Beck, Laurence H., MD, PhD, van Rie, Henk, Wirtz, Joris J.J.M., MD, PhD, Verseput, Gaico H., MD, PhD, Frenken, Leon A., MD, PhD, Salant, David J., MD, Cohen Tervaert, Jan Willem, MD, PhD

Get full text

Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19 by Busch, Matthias H., Timmermans, Sjoerd A.M.E.G., Nagy, Magdolna, Visser, Mayken, Huckriede, Joram, Aendekerk, Joop P., de Vries, Femke, Potjewijd, Judith, Jallah, Borefore, Ysermans, Renée, Oude Lashof, Astrid M.L., Breedveld, Paul H., van de Poll, Marcel C.G., van de Horst, Iwan C.C., van Bussel, Bas C.T., Theunissen, Ruud O.M.F.I.H., Spronk, Henri M.H., Damoiseaux, Jan G.M.C., ten Cate, Hugo, Nicolaes, Gerry A.F., Reutelingsperger, Chris P., van Paassen, Pieter

Get full text

New pathophysiological insights and treatment of ANCA-associated vasculitis by Wilde, Benjamin, van Paassen, Pieter, Witzke, Oliver, Tervaert, Jan Willem Cohen

“…ANCA-associated-vasculitis (AAV) comprises three different diseases entities: Churg–Strauss syndrome, microscopic polyangiitis, and Wegener’s granulomatosis…”
Get full text

Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis by Wilde, Benjamin, Slot, Marjan, van Paassen, Pieter, Theunissen, Ruud, Kemna, Michael, Witzke, Oliver, Cohen Tervaert, Jan Willem

“…Background/Aim ANCA‐associated (AAV) vasculitis is an autoimmune small‐vessel vasculitis and may be associated with accelerated atherosclerosis as suggested by…”
Get full text

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts by Leavis, Helen L, van Daele, Paul L A, Mulders-Manders, Catharina, Michels, Renée, Rutgers, Abraham, Legger, Elizabeth, Bijl, Marc, Hak, Elisabeth A, Lam-Tse, Wai-Kwan, Bonte-Mineur, Femke, Fretter, Peter, Simon, Anna, van Paassen, Pieter, van der Goes, Marlies C, Flendrie, Marcel, Vercoutere, Ward, van Lieshout, Antoine W T, Leek, Arjen, Vastert, Sebastiaan J, Tas, Sander W

“…Abstract Objectives Adult-onset Still’s disease (AOSD) is a rare condition characterized by fevers, rash, and arthralgia/arthritis; most doctors treating AOSD…”
Get full text

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry by Henkens, Michiel T.H.M., Weerts, Jerremy, Verdonschot, Job A.J., Raafs, Anne G., Stroeks, Sophia, Sikking, Maurits A., Amin, Hesam, Mourmans, Sanne G.J., Geraeds, Chrit B.G., Sanders‐van Wijk, Sandra, Barandiarán Aizpurua, Arantxa, Uszko‐Lencer, Nicole H.M.K., Krapels, Ingrid P.C., Wolffs, Petra F.G., Brunner, Han G., Leeuwen, Rick E.W., Verhesen, Wouter, Schalla, Simon M., Stipdonk, Antonius W.M., Knackstedt, Christian, Li, Xiaofei, Abdul Hamid, Myrurgia A., Paassen, Pieter, Hazebroek, Mark R., Vernooy, Kevin, Brunner‐La Rocca, Hans‐Peter, Empel, Vanessa P.M., Heymans, Stephane R.B.

“…Aims Heart failure (HF) represents a clinical syndrome resulting from different aetiologies and degrees of heart diseases. Among these, a key role is played by…”
Get full text

Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper by Bossuyt, Xavier, Damoiseaux, Jan, Rasmussen, Niels, van Paassen, Pieter, Hellmich, Bernard, Baslund, Bo, Blockmans, Daniel, Vermeersch, Pieter, Lopez-Hoyos, Marcos, Vercammen, Martine, Barret, Elisa, Hammar, Friederike, Leinfelder, Ulrich, Mahler, Michael, Olschowka, Nina, Roggenbuck, Dirk, Schlumberger, Wolfgang, Walker, Roger, Rönnelid, Johan, Cohen Tervaert, Jan-Willem, Csernok, Elena, Fierz, Walter

Get more information

HLA–DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Cohort Study by Hilhorst, Marc, Arndt, Fabian, Joseph Kemna, Michael, Wieczorek, Stefan, Donner, Yoni, Wilde, Benjamin, Thomas Epplen, Jörg, van Paassen, Pieter, Cohen Tervaert, Jan Willem

“…Objective The antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides (AAVs) form a group of small‐vessel vasculitides with systemic involvement…”
Get full text

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases by Stalman, Eileen W, Wieske, Luuk, van Dam, Koos P J, Kummer, Laura Y, van Kempen, Zoé L E, Killestein, Joep, Volkers, Adriaan G, Tas, Sander W, Boekel, Laura, Wolbink, Gertjan J, Van der Kooi, Anneke J, Raaphorst, Joost, Löwenberg, Mark, Takkenberg, R Bart, D'Haens, Geert R A M, Spuls, Phyllis I, Bekkenk, Marcel W, Musters, Annelie H, Post, Nicoline F, Bosma, Angela L, Hilhorst, Marc L, Vegting, Yosta, Bemelman, Frederique J, Voskuyl, Alexandre E, Broens, Bo, Parra Sanchez, Agner, van Els, Cécile A C M, Wit, Jelle De, Rutgers, Abraham, de Leeuw, Karina, Horváth, Barbara, Verschuuren, Jan J G M, Ruiter, Annabel M, van Ouwerkerk, Lotte, van der Woude, Diane, Allaart, C F, Teng, Onno Y K, van Paassen, Pieter, Busch, Matthias H, Jallah, Papay B P, Brusse, Esther, van Doorn, Pieter A, Baars, Adája Elisabeth, Hijnen, Dirk Jan, Schreurs, Corine R G, Van der Pol, W Ludo, Goedee, H Stephan, Steenhuis, Maurice, Keijzer, Sofie, Keijser, Jim B D, Boogaard, Arend, Cristianawati, Olvi, Ten Brinke, Anja, Verstegen, Niels J M, Zwinderman, Koos A H, Rispens, Theo, van Ham, S Marieke, Kuijpers, Taco W, Eftimov, Filip

“…To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron breakthrough infections between patients with immune-mediated…”
Get more information